ECHOSTAR CORP-A (SATS)

US2787681061 - Common Stock

24.27  -0.41 (-1.66%)

After market: 24.2 -0.07 (-0.29%)

Fundamental Rating

1

SATS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 92 industry peers in the Media industry. Both the profitability and financial health of SATS have multiple concerns. While showing a medium growth rate, SATS is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year SATS has reported negative net income.
SATS had a positive operating cash flow in the past year.
In multiple years SATS reported negative net income over the last 5 years.
SATS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SATS has a Return On Assets (-3.72%) which is comparable to the rest of the industry.
SATS has a Return On Equity (-10.50%) which is in line with its industry peers.
The Return On Invested Capital of SATS (0.48%) is worse than 64.84% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SATS is significantly below the industry average of 7.37%.
Industry RankSector Rank
ROA -3.72%
ROE -10.5%
ROIC 0.48%
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%

1.3 Margins

The Operating Margin of SATS (1.36%) is worse than 67.03% of its industry peers.
In the last couple of years the Operating Margin of SATS has declined.
SATS has a Gross Margin of 27.75%. This is in the lower half of the industry: SATS underperforms 70.33% of its industry peers.
In the last couple of years the Gross Margin of SATS has declined.
Industry RankSector Rank
OM 1.36%
PM (TTM) N/A
GM 27.75%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SATS is destroying value.
Compared to 1 year ago, SATS has more shares outstanding
SATS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SATS has a worse debt to assets ratio.

2.2 Solvency

SATS has an Altman-Z score of 0.77. This is a bad value and indicates that SATS is not financially healthy and even has some risk of bankruptcy.
SATS has a Altman-Z score of 0.77. This is comparable to the rest of the industry: SATS outperforms 45.05% of its industry peers.
SATS has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
SATS's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. SATS is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 0.77
ROIC/WACC0.05
WACC9.04%

2.3 Liquidity

SATS has a Current Ratio of 0.40. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
SATS's Current ratio of 0.40 is on the low side compared to the rest of the industry. SATS is outperformed by 95.60% of its industry peers.
A Quick Ratio of 0.32 indicates that SATS may have some problems paying its short term obligations.
The Quick ratio of SATS (0.32) is worse than 98.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.32

4

3. Growth

3.1 Past

The earnings per share for SATS have decreased strongly by -221.34% in the last year.
The Revenue has grown by 1174.63% in the past year. This is a very strong growth!
The Revenue has been growing by 57.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-221.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.74%
Revenue 1Y (TTM)1174.63%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%772.36%

3.2 Future

SATS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -152.99% yearly.
The Revenue is expected to grow by 1.63% on average over the next years.
EPS Next Y-3290.48%
EPS Next 2Y-648.41%
EPS Next 3Y-347.26%
EPS Next 5Y-152.99%
Revenue Next Year-0.47%
Revenue Next 2Y-2.18%
Revenue Next 3Y-0.77%
Revenue Next 5Y1.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SATS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

SATS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.28

4.3 Compensation for Growth

A cheap valuation may be justified as SATS's earnings are expected to decrease with -347.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-648.41%
EPS Next 3Y-347.26%

0

5. Dividend

5.1 Amount

No dividends for SATS!.
Industry RankSector Rank
Dividend Yield N/A

ECHOSTAR CORP-A

NASDAQ:SATS (11/4/2024, 8:00:02 PM)

After market: 24.2 -0.07 (-0.29%)

24.27

-0.41 (-1.66%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.72%
ROE -10.5%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.36%
PM (TTM) N/A
GM 27.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.4
Quick Ratio 0.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-221.34%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-3290.48%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1174.63%
Revenue growth 3Y108.11%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y